|
| Status |
Public on Dec 04, 2020 |
| Title |
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/pmc/articles/PMC8192696/
|
| |
|
| Citation(s) |
34151238 |
| Submission date |
Dec 01, 2020 |
| Last update date |
Dec 10, 2023 |
| Contact name |
Barry Zee |
| Organization name |
Boston Children's Hospital
|
| Department |
Newborn Medicine
|
| Lab |
Yang Shi
|
| Street address |
61 Binney Street
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02115 |
| Country |
USA |
| |
|
| Platforms (2) |
|
| Samples (18)
|
| GSM4950891 |
ER-HOXA9 Non-treated Day 0 rep2 |
| GSM4950892 |
ER-HOXA9 Vehicle Day 3 rep2 |
| GSM4950893 |
ER-HOXA9 Drug treated Day 3 rep2 |
| GSM4950992 |
ER-HOXA9 Non-treated Day 0 rep1 [ATAC-Seq] |
| GSM4950993 |
ER-HOXA9 Non-treated Day 0 rep2 [ATAC-Seq] |
| GSM4950994 |
ER-HOXA9 Veh treated Day 2 rep1 [ATAC-Seq] |
| GSM4950995 |
ER-HOXA9 Veh treated Day 2 rep2 [ATAC-Seq] |
| GSM4950996 |
ER-HOXA9 LSD1i treated Day 2 rep1 [ATAC-Seq] |
| GSM4950997 |
ER-HOXA9 LSD1i treated Day 2 rep2 [ATAC-Seq] |
| GSM4950998 |
ER-HOXA9 6MP treated Day 2 rep1 [ATAC-Seq] |
| GSM4950999 |
ER-HOXA9 6MP treated Day 2 rep2 [ATAC-Seq] |
| GSM4951000 |
ER-HOXA9 CER treated Day 2 rep1 [ATAC-Seq] |
| GSM4951001 |
ER-HOXA9 CER treated Day 2 rep2 [ATAC-Seq] |
| GSM4951002 |
ER-HOXA9 Combo treated Day 2 rep1 [ATAC-Seq] |
| GSM4951003 |
ER-HOXA9 Combo treated Day 2 rep2 [ATAC-Seq] |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE162390 |
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia [RNA-Seq] |
| GSE162397 |
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia [ATAC-Seq] |
|
| Relations |
| BioProject |
PRJNA681779 |
Less...
More...